193 related articles for article (PubMed ID: 20463834)
1. Hurthle cell tumours of the thyroid. Personal experience and review of the literature.
Barnabei A; Ferretti E; Baldelli R; Procaccini A; Spriano G; Appetecchia M
Acta Otorhinolaryngol Ital; 2009 Dec; 29(6):305-11. PubMed ID: 20463834
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
3. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
4. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
[TBL] [Abstract][Full Text] [Related]
5. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
6. Hurthle cell tumor.
Chen HY; Benjamin LB; Chen MF
Int Surg; 1996; 81(2):168-70. PubMed ID: 8912085
[TBL] [Abstract][Full Text] [Related]
7. Unilateral lobectomy for Hurthle cell adenoma.
Wasvary H; Czako P; Poulik J; Lucas R
Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901
[TBL] [Abstract][Full Text] [Related]
8. Favorable Outcome of Hurthle Cell Carcinoma of the Thyroid Treated With Total Thyroidectomy, Radioiodine, and Selective Use of External-Beam Radiotherapy.
Zavitsanos P; Amdur RJ; Drew PA; Cusi K; Werning JW; Morris CG
Am J Clin Oncol; 2017 Aug; 40(4):433-437. PubMed ID: 25730603
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experience in Hurthle cell tumors].
Francomano F; Napolitano L; Scipione P; Savini F; Bajocchi G; Angelucci D
G Chir; 1998; 19(11-12):449-52. PubMed ID: 9882947
[TBL] [Abstract][Full Text] [Related]
10. Appearance of Hürthle cell carcinoma soon after surgical extirpation of Hürthle cell adenoma and follicular adenoma of the thyroid gland.
Ristevska N; Stojanoski S; Gjorceva DP
Radiol Oncol; 2015 Mar; 49(1):26-31. PubMed ID: 25810698
[TBL] [Abstract][Full Text] [Related]
11. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
12. [Hurthle cell thyroid tumor: an analysis of 28 cases].
Yang XY; Hu CX; Yang LZ; Zhao WC; Pan Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Nov; 45(11):908-11. PubMed ID: 21215204
[TBL] [Abstract][Full Text] [Related]
13. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
[TBL] [Abstract][Full Text] [Related]
14. Hürthle cell tumors of the thyroid gland. Personal experience and review of literature.
Bononi M; De Cesare A; Cangemi V; Fiori E; Galati G; Giovagnoli MR; Izzo L; Cimitan A; Meucci M; Cavallaro A
Anticancer Res; 2002; 22(6B):3579-82. PubMed ID: 12552959
[TBL] [Abstract][Full Text] [Related]
15. Recurrent Hurthle cell thyroid carcinoma does not preclude long-term survival: a case report and review of the literature.
Blossey RD; Kleine-Döpke D; Ringe KI; Pöhnert D; Ringe B; Klempnauer J; Beetz O
J Med Case Rep; 2021 Aug; 15(1):399. PubMed ID: 34376229
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of Hurthle cell tumors of the thyroid.
Chao TC; Lin JD; Chen MF
World J Surg; 2005 Feb; 29(2):164-8. PubMed ID: 15650796
[TBL] [Abstract][Full Text] [Related]
17. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
18. Thyroid follicular carcinoma: sonographic features of 50 cases.
Sillery JC; Reading CC; Charboneau JW; Henrichsen TL; Hay ID; Mandrekar JN
AJR Am J Roentgenol; 2010 Jan; 194(1):44-54. PubMed ID: 20028904
[TBL] [Abstract][Full Text] [Related]
19. Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hürthle cell and/or apocrine-like changes.
Mai KT; Bokhary R; Yazdi HM; Thomas J; Commons AS
Histopathology; 2002 Feb; 40(2):133-42. PubMed ID: 11952857
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
